Both Abbott Laboratories and Medtronic faced Class I Recalls last week. Abbott faced a recall of specific lots of its NC Trek RX Coronary Dilatation Catheter. Medtronic’s MiniMed Insulin Pump was the subject of a recall.
Last week, Insulet revealed it had snared two partnerships that will help it continue its strong momentum in the continuous glucose monitoring (CGM) market. The Billerica, MA-based company signed agreements with both Abbott Laboratories and DexCom.
The Menlo Park, CA-based company said it has initiated PATHFINDER, a multi-center study. PATHFINDER will mark the first time Grail’s test results will be returned to healthcare providers and communicated to participants to help guide appropriate diagnostic workups for more than 50 cancer types.